Over the last year, a good number of insiders have significantly increased their holdings in Recce Pharmaceuticals ...
Human Research Ethics Committee approval received for Phase II trial of R327 for acute bacterial skin and skin structure infections (ABSSSI), including diabetic foot and wound infections New site ...
A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in ...
To get a sense of who is truly in control of Recce Pharmaceuticals Ltd (ASX:RCE), it is important to understand the ownership structure of the business. We can see that retail investors own the lion's ...
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Recce, a new film & TV recommendation app designed to cure content overload and bring clarity to viewer decision fatigue, has launched. With an intuitive interface, and a community centric approach, ...
Recce Pharmaceuticals has secured a cash refund of more than $5.3 million under the Australian Government’s R&D Tax Incentive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results